Other drug stocks are reacting to the FDA decision on Arena Pharmaceuticals (ARNA) Locaserin:...

This news story has 2 comments:

Register or Login to rate comments »

csmsr Comments (9)
 
Perhaps the resistance to a drug for weigtloss has been broken. With ARNA's drug showing a 5% weight loss, vs. VVUS's 10%, it should bode well for VVUS.
10 May 2012, 06:55 PM Reply Like

phemale60 Comments (1708)
 
Congrats to all you ARNA holders!! I think we need both drugs in the pharmacys and the FDA would do right to approve them.
10 May 2012, 09:16 PM Reply Like